Champlain Investment Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Sell
109,230
-175,045
-62% -$37.5M 0.59% 79
2026
Q1
$62.9M Sell
284,275
-40,325
-12% -$9.86M 0.8% 56
2025
Q4
$82.3M Sell
324,600
-64,595
-17% -$16.2M 0.83% 57
2025
Q3
$96.3M Sell
389,195
-27,644
-7% -$6.62M 0.73% 57
2025
Q2
$100M Buy
416,839
+13,636
+3% +$3.17M 0.7% 58
2025
Q1
$91.4M Sell
403,203
-144,245
-26% -$31.7M 0.66% 64
2024
Q4
$113M Buy
547,448
+23,825
+5% +$5.23M 0.71% 57
2024
Q3
$127M Sell
523,623
-492,780
-48% -$115M 0.77% 57
2024
Q2
$223M Sell
1,016,403
-19,058
-2% -$4.14M 1.37% 18
2024
Q1
$233M Sell
1,035,461
-27,130
-3% -$6.12M 1.33% 22
2023
Q4
$234M Sell
1,062,591
-15,886
-1% -$3.36M 1.39% 19
2023
Q3
$237M Sell
1,078,477
-2,865
-0.3% -$648K 1.54% 12
2023
Q2
$243M Buy
1,081,342
+3,650
+0.3% +$730K 1.5% 16
2023
Q1
$206M Sell
1,077,692
-48,300
-4% -$9.34M 1.3% 19
2022
Q4
$208M Buy
1,125,992
+84,626
+8% +$14.9M 1.33% 15
2022
Q3
$173M Sell
1,041,366
-22,250
-2% -$4.53M 1.18% 24
2022
Q2
$219M Sell
1,063,616
-18,385
-2% -$4.15M 1.42% 13
2022
Q1
$262M Sell
1,082,001
-480,221
-31% -$111M 1.35% 14
2021
Q4
$380M Sell
1,562,222
-52,089
-3% -$11.9M 1.72% 7
2021
Q3
$330M Sell
1,614,311
-71,126
-4% -$15.2M 1.58% 12
2021
Q2
$348M Buy
+1,685,437
New +$339M 1.65% 9
2018
Q3
Sell
-131,880
Closed -$13.8M 121
2018
Q2
$13.8M Sell
131,880
-656,680
-83% -$66.1M 0.13% 114
2018
Q1
$73.6M Sell
788,560
-139,975
-15% -$12.7M 0.8% 59
2017
Q4
$81.2M Sell
928,535
-155,755
-14% -$13.9M 0.92% 42
2017
Q3
$95.9M Sell
1,084,290
-181,720
-14% -$15.4M 1.13% 31
2017
Q2
$103M Buy
1,266,010
+30,410
+2% +$2.31M 1.26% 23
2017
Q1
$85.8M Buy
1,235,600
+150,885
+14% +$10.4M 1.13% 27
2016
Q4
$73.1M Buy
1,084,715
+57,115
+6% +$3.87M 1.01% 29
2016
Q3
$75.1M Buy
1,027,600
+129,115
+14% +$9.12M 1.14% 23
2016
Q2
$61.8M Buy
898,485
+431,945
+93% +$30.3M 1.06% 27
2016
Q1
$33.1M Buy
466,540
+5,250
+1% +$355K 0.6% 76
2015
Q4
$34.8M Sell
461,290
-671,745
-59% -$48.5M 0.59% 76
2015
Q3
$73.6M Sell
1,133,035
-8,450
-0.7% -$558K 1.29% 17
2015
Q2
$73.6M Sell
1,141,485
-356,880
-24% -$24.1M 1.16% 26
2015
Q1
$105M Buy
1,498,365
+266,670
+22% +$17.6M 1.8% 8
2014
Q4
$79.9M Buy
1,231,695
+52,625
+4% +$3.25M 1.27% 21
2014
Q3
$63.6M Sell
1,179,070
-22,675
-2% -$1.23M 1.1% 24
2014
Q2
$64.3M Buy
1,201,745
+50,275
+4% +$2.59M 1.05% 27
2014
Q1
$55M Sell
1,151,470
-29,285
-2% -$1.37M 0.95% 33
2013
Q4
$56.7M Sell
1,180,755
-19,185
-2% -$877K 1% 30
2013
Q3
$51.5M Sell
1,199,940
-1,675
-0.1% -$72.8K 0.98% 37
2013
Q2
$51.5M Buy
+1,201,615
New +$51.7M 1.04% 29

Other funds holding STE

Champlain Investment Partners's STE Position: Q2 2026 in Review

Champlain Investment Partners reduced its Steris (STE) stake by 62% in Q2 2026, selling an estimated $37.5M and leaving 109,230 shares worth $23M. The position accounts for 0.59% of the portfolio, ranked #79.

Champlain Investment Partners first reported a position in STE in Q2 2013 and has held it in 42 quarters since. The position peaked at $380M in Q4 2021. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Champlain Investment Partners held 109,230 shares of Steris worth $23M as of Q2 2026.
  • Champlain Investment Partners sold 175,045 Steris shares in Q2 2026, an estimated $37.5M.
  • Steris made up 0.59% of Champlain Investment Partners's portfolio in Q2 2026, its #79 holding.
  • Champlain Investment Partners first reported a position in Steris in Q2 2013 and has held it in 42 quarters since.
  • Champlain Investment Partners's Steris position peaked at $380M in Q4 2021.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.